Patents Assigned to INVENTISBIO INC.
  • Selective estrogen receptor degraders and uses thereof
    Patent number: 10647724
    Abstract: The present disclosure provides compounds of Formula (I) and Formula (II). The compounds described herein may be useful in treating proliferative diseases (e.g., cancer). Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: May 12, 2020
    Assignee: INVENTISBIO INC.
    Inventors: Xing Dai, Yaolin Wang